DBX ETF Trust has filed its latest NPORT-P report, showcasing significant financial metrics for its Xtrackers MSCI EAFE Hedged Equity ETF. The filing reveals that the company holds total assets of approximately $9.6 billion, indicating a robust position in the investment landscape.
This update is crucial for DBX ETF Trust as it demonstrates the firm’s ability to attract and manage substantial assets, reflecting investor confidence in its offerings. In an industry where growth and asset management are key indicators of success, this filing underscores the company's competitive edge.
Background
DBX ETF Trust is an investment entity incorporated in Delaware. It specializes in managing exchange-traded funds (ETFs), which are popular among investors for their liquidity and diversification benefits. The company has recently filed multiple forms, including several NPORT-P submissions on October 29, 2026, indicating ongoing regulatory compliance and transparency in its operations.
What the Filing Says
The latest filing, dated October 29, 2026, provides detailed financial information about the Xtrackers MSCI EAFE Hedged Equity ETF. According to the report, the total assets under management stand at $9,613,882,944.91, while total liabilities are reported at $217,997,127.95, leading to net assets of approximately $9,395,885,816.96.
Additionally, the filing indicates that the fund has experienced various returns, with a monthly total return of 2.45% for one month, 1.06% for two months, and 1.51% for three months. This performance data is vital for investors assessing the fund's profitability and risk.
Impact
This filing may impact a range of stakeholders, including investors, financial analysts, and competitors in the ETF space. Investors will closely monitor the performance metrics and asset growth, as they are indicative of the fund's potential for future returns. Competitors may analyze these figures to gauge DBX ETF Trust's market position and strategize accordingly.
What's Next
The filing does not specify what happens next for DBX ETF Trust. However, continued monitoring of asset performance and potential future filings will be essential for stakeholders interested in the company's trajectory.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






